What is the relationship between CDISC and Health Level Seven (HL7)?
CDISC has an Associate Charter Agreement (MOU) with HL7 that was originally signed in 2001 and is renewed approximately every two years. The Charter Agreement encourages a relationship that focuses on harmonization of the CDISC clinical research standards and the HL7 healthcare standards. To this end, BRIDG was initiated in 2004 and is now a collaborative model (www.bridgmodel.org) governed by a Board comprised of CDISC, HL7, NCI, NIH and FDA. The newest Charter Agreement allows for “CDISC content-rich HL7 messages to be jointly owned and posted in the members’ area of the websites for both CDISC and HL7”. The LAB model was the first CDISC content model for which an HL7 V3 message was developed (The LAB standard content can also be transported via CDISC ODM, XML, SAS, ASCII). The CDISC President and CEO, Rebecca Kush, was recently elected to the HL7 Board of Directors. The current HL7 CEO served 6 years on the CDISC Board before taking his HL7 CEO position. These relationships can faci
